Unfortunately, in some cases people dont know exactly what they are receiving when purchasing these products. Tenille Davis, PharmD, RPh, BCSCP, FAPC, chief advocacy officer for the Alliance for Pharmacy Compounding, said compounding pharmacies are beholden to regulations within their respective states
Early findings suggest that patients with stable, quiescent disease may tolerate GLP-1 therapy, while those with active inflammation or stricturing disease face higher complication risk
Long-term safety data remains limited compared to established fat-dissolving agents such as deoxycholic acid (Aqualyx, Kybella)
Summer Bodies Start with Science: Why GLP-1 Treatments Like Mounjaro and Ozempic Are in High Demand Jul 9, 2025 2 min read Summer is officially hereand that means long days, beach weekends, and plenty of reasons to feel confident in your own skin
Well just have to wait and see, says Kenakin.